(Q45737780)

15 December 2017

Anti-CD73 therapy impairs tumor angiogenesis (English)

1 reference

15 December 2017

1 reference

5

1 reference

15 December 2017

Bertrand Allard

1

1 reference

15 December 2017

Martin Turcotte

2

1 reference

15 December 2017

Kathleen Spring

3

1 reference

15 December 2017

Sandra Pommey

4

1 reference

15 December 2017

John Stagg

6

1 reference

15 December 2017

language of work or name

English

0 references

publication date

18 September 2013

1 reference

International Journal of Cancer

15 December 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

15 December 2017

134

1 reference

15 December 2017

6

1 reference

15 December 2017

1466-1473

1 reference

CD73: a potent suppressor of antitumor immune responses

15 December 2017

1 reference

Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia

21 January 2018

1 reference

Chronic hypoxia enhances adenosine release in rat PC12 cells by altering adenosine metabolism and membrane transport

21 January 2018

1 reference

Role of estrogen receptor in the regulation of ecto-5'-nucleotidase and adenosine in breast cancer

21 January 2018

1 reference

NT5E (CD73) is epigenetically regulated in malignant melanoma and associated with metastatic site specificity

21 January 2018

1 reference

NT5E CpG island methylation is a favourable breast cancer biomarker

21 January 2018

1 reference

A2A adenosine receptor protects tumors from antitumor T cells.

21 January 2018

1 reference

Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia

21 January 2018

1 reference

Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis

21 January 2018

1 reference

CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis

21 January 2018

1 reference

CD73-deficient mice are resistant to carcinogenesis

21 January 2018

1 reference

CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice

21 January 2018

1 reference

CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression

21 January 2018

1 reference

Hypoxia promotes tumor growth in linking angiogenesis to immune escape

21 January 2018

1 reference

Extracellular adenosine signaling in molecular medicine

21 January 2018

1 reference

Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery

21 January 2018

1 reference

Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism

21 January 2018

1 reference

HIF-dependent induction of adenosine A2B receptor in hypoxia

21 January 2018

1 reference

Adenosine A(2A) receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis.

21 January 2018

1 reference

Differential expression of adenosine receptors in human endothelial cells: role of A2B receptors in angiogenic factor regulation

21 January 2018

1 reference

Hypoxia modulates adenosine receptors in human endothelial and smooth muscle cells toward an A2B angiogenic phenotype

21 January 2018

1 reference

Secreted and cell-associated adenylate kinase and nucleoside diphosphokinase contribute to extracellular nucleotide metabolism on human airway surfaces

21 January 2018

1 reference

Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia

21 January 2018

1 reference

Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors

21 January 2018

1 reference

Lack of ecto-5'-nucleotidase (CD73) promotes arteriogenesis.

21 January 2018

1 reference

Tenascin C interacts with ecto-5'-nucleotidase (eN) and regulates adenosine generation in cancer cells.

21 January 2018

1 reference

Ecto-5'-nucleotidase/CD73 knockdown increases cell migration and mRNA level of collagen I in a hepatic stellate cell line

21 January 2018

1 reference

CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73

21 January 2018

1 reference

Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors

21 January 2018

1 reference

In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro

21 January 2018

1 reference

Extracellular adenosine triphosphate and adenosine in cancer.

21 January 2018

1 reference

Ecto-5'-nucleotidase (CD73) promotes tumor angiogenesis

21 January 2018

1 reference

Host A(2B) adenosine receptors promote carcinoma growth

21 January 2018

1 reference

Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1.

21 January 2018

1 reference

Adenosine A2A receptor is a unique angiogenic target of HIF-2alpha in pulmonary endothelial cells.

21 January 2018

1 reference

CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer

21 January 2018

1 reference

Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28456

1 reference

15 December 2017

1 reference